latest update:
[TrialBase DB]

trial summary · NCT07748793

Autologous Fat Grafting for the Treatment of Chronic Tendinopathy

Trial record from the TrialBase DB dataset, status RECRUITING, condition Chronic Tendinopathy, sponsored by Weill Medical College of Cornell University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07748793phase —enrollment 40start 2026-10-31

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The goal of this clinical trial is to learn whether a one-time injection of a person's own processed fat tissue (autologous lipoaspirate), a procedure called Adipose Stem/Stromal Cells for Enthesis/Tendon Therapy (ASSET), can reduce pain and improve function in adults (ages 18-80) with chronic tendinopathy- tendon pain lasting more than 3 months (for example, in the shoulder, elbow, hip, knee, or Achilles) - that has not improved with usual treatments such as physical therapy, cortisone shots, or platelet-rich plasma. The main questions it aims to answer are: * Does injecting a person's own concentrated fat into a painful tendon reduce tendon pain? * Does it improve how well the tendon works, how long does any improvement last, and is the procedure safe? This is a single-group study, so there is no separate comparison group; each participant's pain, function, and ultrasound results after treatment are compared with their own measurements taken before treatment. Participants will: * Have a one-time procedure in which a small amount of fat is removed from the abdomen by liposuction (under local numbing), concentrated, and injected into the painful tendon using ultrasound guidance. * Complete short pain and function questionnaires and have ultrasound imaging of the tendon at study visits. * Be followed for about 12 months, with a phone or video check-in 3-7 days after the procedure, a 2-week skin check of the fat-removal site, and visits at 6 weeks, 3 months, 6 months, and 12 months.

Source record: https://clinicaltrials.gov/study/NCT07748793

Facts

registry idNCT07748793
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionChronic Tendinopathy
sponsorWeill Medical College of Cornell University
sponsor classOTHER
enrollment40
start date2026-10-31
primary completion2028-01
completion2028-07
results postednot reported

Conditions

  • Chronic Tendinopathy

Interventions

  • Adipose Stem/Stromal Cells for Enthesis/Tendon Therapy (ASSET) Injection

Countries

  • United States

Intervention types: PROCEDURE

Work with this record